from statistical analye globe.
When you're newly
diagnosed, you
cling on to all
news of research
into a cure for
diabetes. You hope that you'll have to
cope for a few years, but then you will
be healed. Then you start to realise that
while there are huge amounts of research
out there, it means resources are spread
thinly, and that medical research and
development (R&D) is a very slow game
indeed. But that's not to say that great
gains are being made, and some of us
are now using drugs and technology
that wasn't imagined (or was only just
imagined) a decade ago.
On 20 May 2014 people with diabetes
talked directly to leaders from medicine,
academia and industry about how
the condition affects their daily lives.
The IMI-JDRF Diabetes Patient Focus
Meeting was held to identify research and
development gaps in the diabetes area
from the perspective of patient needs and
challenges.
The Innovative Medicines Initiative
(IMI) is the world's largest publicprivate
partnership in health - a joint
undertaking between the European
Union and the pharmaceutical industry
association EFPIA. JDRF is the leading
global charity funding Type 1 diabetes
research, currently sponsoring research
in 17 countries. Karen Addington, Chief
Executive of JDRF UK, commented on
the event saying, "Research progress
in Type 1 diabetes has never been
faster than it is today. There are now
tangible opportunities for research to
transform the lives of people affected
by the condition. But it is crucial that
those people are placed at the heart of
the research dialogue. Only by doing this
can we achieve our goal of progressively continued over
LIVING